|
Laura A. Brege joined Onyx as Executive Vice President and Chief Business Officer in June 2006. Previously, Ms. Brege was a General Partner at Red Rock Management, a venture capital firm specializing in early stage financing for technology companies. Prior to Red Rock, she was the Senior Vice President and Chief Financial Officer at COR Therapeutics, a biotechnology company that specialized in drug therapies for cardiovascular disease. While at COR, Ms. Brege was instrumental in helping the company grow from a research and development start-up to an operations-based enterprise with a commercialized product. She was also a member of the management team that negotiated multiple corporate partnerships, including a worldwide co-promotion agreement for COR's lead product, as well as corporate partnerships for earlier programs and products with J&J, Eli Lilly, and Solvay. Before joining COR, Ms. Brege was Vice President and Chief Financial Officer at Flextronics, a multi-billion dollar electronics manufacturer. She was also Vice President and Treasurer of The Cooper Companies, a Fortune 500 diversified company with operations worldwide. Ms. Brege earned her undergraduate degree from Ohio University and has an MBA from the University of Chicago. | 